NMVZX | VMVAX | NMVZX / VMVAX | |
Total Expense Ratio | 0.79 | 0.07 | 1,129% |
Annual Report Gross Expense Ratio | 0.84 | 0.07 | 1,200% |
Fund Existence | 8 years | 14 years | - |
Gain YTD | 2.360 | 3.334 | 71% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 3000 | 83% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 520M | 29.9B | 2% |
Annual Yield % from dividends | 2.79 | 2.26 | 123% |
Returns for 1 year | 5.24 | 11.88 | 44% |
Returns for 3 years | 1.40 | 28.23 | 5% |
Returns for 5 years | 9.47 | 76.67 | 12% |
Returns for 10 years | N/A | 87.68 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
MCHS | 29.34 | 0.27 | +0.93% |
Matthews China Discovery Active ETF | |||
KOOL | 11.89 | 0.11 | +0.92% |
North Shore Equity Rotation ETF | |||
IUSV | 96.34 | 0.50 | +0.52% |
iShares Core S&P US Value ETF | |||
PCN | 12.75 | 0.03 | +0.24% |
PIMCO Corporate & Income Strategy Fund | |||
UTEN | 43.39 | -0.15 | -0.34% |
F/m US Treasury 10 Year Note ETF |